JPS58222026A - 抗ガン性物質 - Google Patents

抗ガン性物質

Info

Publication number
JPS58222026A
JPS58222026A JP57103905A JP10390582A JPS58222026A JP S58222026 A JPS58222026 A JP S58222026A JP 57103905 A JP57103905 A JP 57103905A JP 10390582 A JP10390582 A JP 10390582A JP S58222026 A JPS58222026 A JP S58222026A
Authority
JP
Japan
Prior art keywords
substance
solution
molecular weight
fraction
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57103905A
Other languages
English (en)
Japanese (ja)
Other versions
JPS632415B2 (enExample
Inventor
Masahiro Yoshimura
吉村　政弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP57103905A priority Critical patent/JPS58222026A/ja
Publication of JPS58222026A publication Critical patent/JPS58222026A/ja
Publication of JPS632415B2 publication Critical patent/JPS632415B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP57103905A 1982-06-18 1982-06-18 抗ガン性物質 Granted JPS58222026A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57103905A JPS58222026A (ja) 1982-06-18 1982-06-18 抗ガン性物質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57103905A JPS58222026A (ja) 1982-06-18 1982-06-18 抗ガン性物質

Publications (2)

Publication Number Publication Date
JPS58222026A true JPS58222026A (ja) 1983-12-23
JPS632415B2 JPS632415B2 (enExample) 1988-01-19

Family

ID=14366435

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57103905A Granted JPS58222026A (ja) 1982-06-18 1982-06-18 抗ガン性物質

Country Status (1)

Country Link
JP (1) JPS58222026A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
FR2569983A1 (fr) * 1984-09-13 1986-03-14 Shigezo Udaka Substance tumoricide spf-140 et procede pour sa preparation
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
FR2569983A1 (fr) * 1984-09-13 1986-03-14 Shigezo Udaka Substance tumoricide spf-140 et procede pour sa preparation
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria

Also Published As

Publication number Publication date
JPS632415B2 (enExample) 1988-01-19

Similar Documents

Publication Publication Date Title
Gleich et al. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.
Theodosis et al. Oxytocin induces morphological plasticity in the adult hypothalamo-neurohypophysial system
DK174603B1 (da) Anvendelse af granulocyt makrofag kolonistimulerende faktor til fremstilling af et medikament til fremme af tumoricid aktivitet
Mishell et al. Immunization of normal mouse spleen cell suspensions in vitro
EP0285059B1 (en) Monoclonal antibodies against glycolipid antigens and their use
JP5735280B2 (ja) 組換えマンネンタケ（Ｇａｎｏｄｅｒｍａｌｕｃｉｄｉｕｍ）免疫調節タンパク質（ｒＬＺ−８）およびその使用
CH664974A5 (fr) Production du facteur de lyse des cellules-cibles.
JP2002531050A (ja) 抗メチオニンおよび抗ホモシステイン化学療法におけるメチオニナーゼの使用
CN112386678B (zh) 多肽或其衍生物的应用
CN101991608A (zh) 蝇蛆提取物及其制备方法和用途
EP0132125B2 (en) A protein having antitumor activity
Seljelid et al. Evidence that Tumour Necrosis Induced by Aminated β1‐3D Polyglucose is Mediated by a Concerted Action of Local and Systemic Cytokines
JPH06504039A (ja) ヒトの治療に有用なポリペプチド性物質
JPS6133008B2 (enExample)
CN107022557A (zh) 新的死亡受体5抗体融合蛋白及其应用
KR0150000B1 (ko) 사람 macif 활성을 지닌 단백질을 암호화하는 유전자, 이 유전자를 함유하는 발현 벡터, 형질전환 세포 및 사람 macif 활성을 갖는 단백질
JP2021527664A (ja) 合成ペプチドｓｐ２及びその用途
EP0353861B1 (en) Angiogenesis inhibitor
NO793412L (no) Fremgangsmaate for fremstilling av overfoeringsfaktor mot patogene antigener
JPS58222026A (ja) 抗ガン性物質
Bodenheimer Jr et al. Characterization of a new monoclonal antibody to rat macrophages and Kupffer cells
EP0363703A1 (en) Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof
Yamashita et al. Intestinal absorption and urinary excretion of antitumor peptidomannan KS-2 after oral administration in rats
EP0145775B1 (en) A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A $g(g)-INTERFERON CONTAINING PREPARATION
JP2010099094A (ja) メチオニナーゼの産生法